Editor’s note: This is general educational information about how share repurchase authorisations work under United States law and disclosure rules. It is not investment advice and does not concern any particular company. It draws on the SEC and Delaware sources listed at the end.
Analysis: reading the number a board actually chose
The size of an authorisation is a governance signal, not a cash-flow forecast. The three regimes explain why. Delaware sets the outer boundary and ties it to capital impairment, which is a balance sheet test that moves. The safe harbour sets the daily pace, which ties execution to the stock’s own trading volume. The disclosure table then reports, month by month, what was actually done. A headline figure is chosen against all three, and the third is the one that reaches the public record.
That makes the volume condition the most useful piece of context for a reader trying to judge whether an authorisation is large. A programme sized at a large fraction of the company’s market value cannot be executed quickly in the open market if daily purchases are held to 25% of four-week average daily trading volume. The arithmetic of how long an authorisation would take to spend at that pace is a matter for the reader’s own calculation from the company’s own volume figures, but the constraint is in the rule, not in the announcement.
The disclosure table also establishes and fails to establish specific things. It establishes how many shares were bought each month, at what average price, and how much authorisation remains. It does not establish why the board chose the number, whether the company considered a dividend instead, or what the shares were expected to be worth. It does not distinguish repurchases funded from operating cash from those funded by new debt. And because the safe harbour is voluntary, a company buying outside its conditions is not disclosing that fact through the table.
What a careful reader can do is compare the announcement footnote with the last column across consecutive filings. An authorisation announced and then barely drawn down, or one that expires with a large remainder, says something different from one spent evenly quarter after quarter. Those two patterns produce the same headline number on the day of the announcement.
What the documents say
A board announces that it has authorised the repurchase of a fixed dollar amount of the company’s stock, and the number is treated as news. It is worth being precise about what the number is. An authorisation is a ceiling granted by directors, not a commitment to spend, not a purchase order, and not the legal limit on what the company may buy. Three separate bodies of rule sit behind it, and each one governs a different part of the number.
What the board is actually approving
Under Delaware corporate law, a corporation may purchase, redeem, receive, take or otherwise acquire, own and hold, sell, lend, exchange, transfer or otherwise dispose of, pledge, use and otherwise deal in and with its own shares. That broad grant carries a hard limit. No corporation may purchase or redeem its own shares of capital stock for cash or other property when the capital of the corporation is impaired, or when the purchase would cause any impairment of that capital. There is a narrow exception for shares carrying a preference on distribution, or, where no preferred shares are outstanding, for shares that will be retired on acquisition with capital reduced accordingly.
The statute adds two further constraints that rarely make headlines. A corporation may not purchase, for more than the price at which they may then be redeemed, any of its shares that are redeemable at its option. Redemption of shares requires authorisation under the section of the statute governing that class, and then only in accordance with that section and the certificate of incorporation.
So the legal capacity to repurchase is set by the state of incorporation and by the balance sheet, not by the board resolution. A board authorisation sits inside that capacity. It tells management how much the directors are willing to see spent, over what period, before coming back for more.
Why the announced figure is a ceiling and not a plan
The SEC’s disclosure regime makes the gap between authorisation and execution visible every quarter. When the Commission amended the rules governing issuer repurchases, it required periodic disclosure of all issuer repurchases, open market and private transactions alike, regardless of whether they were effected under the safe harbour for issuer repurchases. The requirement is independent of that safe harbour.
The result is a table. For its last fiscal quarter, an issuer must disclose the total number of shares purchased, reported on a monthly basis, the average price paid per share, the total number of shares purchased as part of publicly announced plans or programs, and the maximum number, or approximate dollar value, of shares that may yet be purchased under those plans or programs. Form 10-Q carries the table under the item covering unregistered sales of equity securities, and the instruction is explicit that the months follow the fiscal quarter rather than the calendar: where a quarter began on January 16 and ended on April 15, the chart shows the periods from January 16 through February 15, February 16 through March 15, and March 16 through April 15.
Footnotes carry the terms of the programme itself: the date of announcement, the share or dollar amount approved, the expiration date if there is one, each plan that expired during the period covered by the table, and each plan the issuer has decided to terminate early or under which it does not intend to buy further. The last column, showing what may yet be purchased, is the running remainder of the authorisation. Read across several quarters it shows whether a company is spending its authorisation, sitting on it, or letting it lapse.
The daily limits that shape execution
How fast an authorisation can be spent in the open market is governed by a separate mechanism. The Commission adopted Rule 10b-18 in 1982 as a safe harbour: an issuer is not deemed to have violated the anti-manipulation provisions solely by reason of the manner, timing, price or volume of its repurchases if it buys in accordance with the rule’s conditions. Compliance is voluntary, the safe harbour is not the exclusive means of making non-manipulative repurchases, and there is no presumption that purchases outside it are manipulative.
The conditions are daily and cumulative. Failure to meet any one of the four removes all of that day’s repurchases from the safe harbour. The manner condition requires the issuer to use a single broker or dealer per day for solicited purchases. The timing condition keeps the issuer out of the opening transaction and, historically, out of the last half hour of trading, on the reasoning that activity at those times is a significant indicator of the direction of trading, the strength of demand and the current market value of the security. The price condition, as amended, limits the issuer to a price no higher than the highest independent bid or the last independent transaction price, whichever is higher. The volume condition caps daily purchases at 25% of average daily trading volume in the shares, measured over four weeks.
Block purchases are treated separately. The rule defines a block as a quantity of stock with a purchase price of $200,000 or more, or at least 5,000 shares with a purchase price of at least $50,000, or at least 20 round lots totalling 150 percent or more of the security’s trading volume, or, where volume data are unavailable, at least 20 round lots totalling at least one-tenth of one percent of the outstanding shares excluding affiliate holdings. The amendments folded block purchases into the average daily volume calculation and into the 25% limitation, and created an alternative condition raising that limitation to 100% during the trading session immediately following a market-wide trading suspension. After a merger or similar transaction is announced, daily repurchases within the safe harbour are held to the lesser of 25% of four-week average daily volume or the issuer’s average daily repurchases during the three full calendar months preceding the announcement.
